NOTCH1 and acute lymphoblastic leukemia: Recently, it has been reported that loss of Ptch1 function is able to accelerate the onset of Notch1-induced human T-ALL, demonstrating that Hh pathway mutations are driver oncogenic alterations, providing a molecular rationale for targeted therapy (Burns et al., 2018).